Glutathione S-transferase copy number variation alters lung gene expression

European Respiratory Journal

Volumn 38, Issue 1, 2011, Pages 15-28

  Butler, M W ^a   Hackett, N R ^a   Salit, J ^a   Strulovici Barel, Y ^a   Omberg, L ^b   Mezey, J ^a,b   Crystal, R G ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b Plant Breeding and Genetics Section in the School of Integrative Plant Science   (United States)

Author keywords

Gene expression; Gene expression microarrays

Indexed keywords

GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE T1; GLUTATHIONE TRANSFERASE T2B; MESSENGER RNA; UNCLASSIFIED DRUG;

ADULT; ALLELE; ARTICLE; BRONCHOSCOPY; CIGARETTE SMOKING; CONTROLLED STUDY; COPY NUMBER VARIATION; FEMALE; GENE; GENE DELETION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC POLYMORPHISM; GENOTYPE; GST GENE; GSTT1 GENE; GSTT2B GENE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUMAN CELL; LUNG ALVEOLUS MACROPHAGE; MALE; MICROARRAY ANALYSIS; NORMAL HUMAN; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM; WILD TYPE;

ADULT; ALLELES; FEMALE; GENE DOSAGE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENOTYPE; GLUTATHIONE TRANSFERASE; HOMOZYGOTE; HUMANS; LUNG; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMORPHISM, GENETIC;

EID: 79960182455     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00029210     Document Type: Article

References (81)

1. Pryor WA, Prier DG, Church DF. Electron-spin resonance study of mainstream and sidestream cigarette smoke: nature of the free radicals in gas-phase smoke and in cigarette tar. Environ Health Perspect 1983; 47: 345-355. (Pubitemid 13134676)
2. Hecht SS. Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst 1999; 91: 1194-1210. (Pubitemid 29357186)
3. Macnee W, Rahman I. Oxidants and antioxidants as therapeutic targets in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 160: S58-S65.
4. Hecht SS. Tobacco carcinogens, their biomarkers and tobacco-induced cancer. Nat Rev Cancer 2003; 3: 733-744. (Pubitemid 37328812)
5. Hogg JC, Macklem PT, Thurlbeck WM. Site and nature of airway obstruction in chronic obstructive lung disease. N Engl J Med 1968; 278: 1355-1360.
6. Niewoehner DE, Kleinerman J, Rice DB. Pathologic changes in the peripheral airways of young cigarette smokers. N Engl J Med 1974; 291: 755-758.
7. Yanai M, Sekizawa K, Ohrui T, et al. Site of airway obstruction in pulmonary disease: direct measurement of intrabronchial pressure. J Appl Physiol 1992; 72: 1016-1023.
8. Rosado-de-Christenson ML, Templeton PA, Moran CA. Bronchogenic carcinoma: radiologic-pathologic correlation. Radiographics 1994; 14: 429-446.
9. Barnes PJ, Shapiro SD, Pauwels RA. Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Eur Respir J 2003; 22: 672-688. (Pubitemid 37258549)
10. Celli BR, Macnee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004; 23: 932-946. (Pubitemid 38807371)
11. Hogg JC, Chu F, Utokaparch S, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004; 350: 2645-2653. (Pubitemid 38787999)
12. Petty RD, Nicolson MC, Kerr KM, et al. Gene expression profiling in non-small cell lung cancer: from molecular mechanisms to clinical application. Clin Cancer Res 2004; 10: 3237-3248. (Pubitemid 38685427)
13. Wistuba II. Genetics of preneoplasia: lessons from lung cancer. Curr Mol Med 2007; 7: 3-14. (Pubitemid 46322275)
14. Kim V, Rogers TJ, Criner GJ. New concepts in the pathobiology of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2008; 5: 478-485. (Pubitemid 351669174)
15. Sturton G, Persson C, Barnes PJ. Small airways: an important but neglected target in the treatment of obstructive airway diseases. Trends Pharmacol Sci 2008; 29: 340-345.
16. Tuder RM, Yoshida T, Arap W, et al. State of the art. Cellular and molecular mechanisms of alveolar destruction in emphysema: an evolutionary perspective. Proc Am Thorac Soc 2006; 3: 503-510.
17. Sharafkhaneh A, Hanania NA, Kim V. Pathogenesis of emphysema: from the bench to the bedside. Proc Am Thorac Soc 2008; 5: 475-477. (Pubitemid 351669173)
18. Lohmann-Matthes ML, Steinmuller C, Franke-Ullmann G. Pulmonary macrophages. Eur Respir J 1994; 7: 1678-1689. (Pubitemid 24294256)
19. Willey JC, Coy E, Brolly C, et al. Xenobiotic metabolism enzyme gene expression in human bronchial epithelial and alveolar macrophage cells. Am J Respir Cell Mol Biol 1996; 14: 262-271. (Pubitemid 126439820)
20. Pulmonary macrophages. In: Crystal RG, West JB, Weibel ER, et al., eds. The Lung: Scientific Foundations. Philadelphia, Lippincott-Raven, 1997; pp. 859-876.
21. Hukkanen J, Pelkonen O, Hakkola J, et al. Expression and regulation of xenobiotic-metabolizing cytochrome P450 (CYP) enzymes in human lung. Crit Rev Toxicol 2002; 32: 391-411. (Pubitemid 35191358)
22. Tetley TD. Macrophages and the pathogenesis of COPD. Chest 2002; 121: 156S-159S.
23. Chow CK. Cigarette smoking and oxidative damage in the lung. Ann NY Acad Sci 1993; 686: 289-298. (Pubitemid 23204434)
24. Heguy A, O'Connor TP, Luettich K, et al. Gene expression profiling of human alveolar macrophages of phenotypically normal smokers and nonsmokers reveals a previously unrecognized subset of genes modulated by cigarette smoking. J Mol Med 2006; 84: 318-328.
25. Birrell MA, Wong S, Catley MC, et al. Impact of tobacco-smoke on key signaling pathways in the innate immune response in lung macrophages. J Cell Physiol 2008; 214: 27-37. (Pubitemid 350220056)
26. Wallace AM, Sandford AJ, English JC, et al. Matrix metalloproteinase expression by human alveolar macrophages in relation to emphysema. COPD 2008; 5: 13-23. (Pubitemid 351225520)
27. Winkler AR, Nocka KH, Sulahian TH, et al. In vitro modeling of human alveolar macrophage smoke exposure: enhanced inflammation and impaired function. Exp Lung Res 2008; 34: 599-629.
28. Shaykhiev R, Krause A, Salit J, et al. Smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of chronic obstructive pulmonary disease. J Immunol 2009; 183: 2867-2883.
29. Singhal SS, Saxena M, Ahmad H, et al. Glutathione S-transferases of human lung: characterization and evaluation of the protective role of the α-class isozymes against lipid peroxidation. Arch Biochem Biophys 1992; 299: 232-241. (Pubitemid 23029025)
30. Cantlay AM, Smith CA, Wallace WA, et al. Heterogeneous expression and polymorphic genotype of glutathione S-transferases in human lung. Thorax 1994; 49: 1010-1014. (Pubitemid 24315995)
31. Seidegard J, Ekstrom G. The role of human glutathione transferases and epoxide hydrolases in the metabolism of xenobiotics. Environ Health Perspect 1997; 105: Suppl. 4, 791-799. (Pubitemid 27372964)
32. Hayes JD, Flanagan JU, Jowsey IR. Glutathione transferases. Annu Rev Pharmacol Toxicol 2005; 45: 51-88. (Pubitemid 40261798)
33. Zhang JY, Wang Y, Prakash C. Xenobiotic-metabolizing enzymes in human lung. Curr Drug Metab 2006; 7: 939-948. (Pubitemid 44873716)
34. Harju T, Mazur W, Merikallio H, et al. Glutathione-S-transferases in lung and sputum specimens, effects of smoking and COPD severity. Respir Res 2008; 9: 80.
35. Chen CL, Liu Q, Relling MV. Simultaneous characterization of glutathione S-transferase M1 and T1 polymorphisms by polymerase chain reaction in American whites and blacks. Pharmacogenetics 1996; 6: 187-191. (Pubitemid 26151949)
36. Gresner P, Gromadzinska J, Wasowicz W. Polymorphism of selected enzymes involved in detoxification and biotransformation in relation to lung cancer. Lung Cancer 2007; 57: 1-25. (Pubitemid 46843341)
37. Norskov MS, Frikke-Schmidt R, Loft S, et al. High-throughput genotyping of copy number variation in glutathione S-transferases M1 and T1 using real-time PCR in 20,687 individuals. Clin Biochem 2009; 42: 201-209.
38. Zhao Y, Marotta M, Eichler EE, et al. Linkage disequilibrium between two high-frequency deletion polymorphisms: implications for association studies involving the glutathione-S transferase (GST) genes. PLoS Genet 2009; 5: e1000472.
39. Henrichsen CN, Chaignat E, Reymond A. Copy number variants, diseases and gene expression. Hum Mol Genet 2009; 18: R1-R8.
40. Henrichsen CN, Vinckenbosch N, Zollner S, et al. Segmental copy number variation shapes tissue transcriptomes. Nat Genet 2009; 41: 424-429.
41. She X, Rohl CA, Castle JC, et al. Definition, conservation and epigenetics of housekeeping and tissue-enriched genes. BMC Genomics 2009; 10: 269.
42. He JQ, Ruan J, Connett JE, et al. Antioxidant gene polymorphisms and susceptibility to a rapid decline in lung function in smokers. Am J Respir Crit Care Med 2002; 166: 323-328. (Pubitemid 34864420)
43. Cheng SL, Yu CJ, Chen CJ, et al. Genetic polymorphism of epoxide hydrolase and glutathione S-transferase in COPD. Eur Respir J 2004; 23: 818-824.
44. Ye Z, Song H, Higgins JP, et al. Five glutathione S-transferase gene variants in 23,452 cases of lung cancer and 30,397 controls: meta-analysis of 130 studies. PLoS Med 2006; 3: e91.
45. Imboden M, Downs SH, Senn O, et al. Glutathione S-transferase genotypes modify lung function decline in the general population: SAPALDIA cohort study. Respir Res 2007; 8: 2.
46. Vineis P, Anttila S, Benhamou S, et al. Evidence of gene gene interactions in lung carcinogenesis in a large pooled analysis. Carcinogenesis 2007; 28: 1902-1905. (Pubitemid 47500601)
47. Harvey BG, Heguy A, Leopold PL, et al. Modification of gene expression of the small airway epithelium in response to cigarette smoking. J Mol Med 2007; 85: 39-53. (Pubitemid 46020941)
48. Clara cells. In: Crystal RG, West JB, Weibel ER, et al., eds. The Lung: Scientific Foundations. Philadelphia, Lippincott-Raven, 1997; pp. 517-534.
49. Use of bronchoalveolar lavage and airway brushing to investigate the human lung. In: Crystal RG, West JB, Weibel ER, et al., eds. The Lung: Scientific Foundations. Philadelphia, Lippincott-Raven, 1997; pp. 371-371.
50. Raman T, O'Connor TP, Hackett NR, et al. Quality control in microarray assessment of gene expression in human airway epithelium. BMC Genomics 2009; 10: 493.
51. Iafrate AJ, Feuk L, Rivera MN, et al. Detection of large-scale variation in the human genome. Nat Genet 2004; 36: 949-951. (Pubitemid 39167488)
52. Moyer AM, Salavaggione OE, Hebbring SJ, et al. Glutathione S-transferase T1 and M1: gene sequence variation and functional genomics. Clin Cancer Res 2007; 13: 7207-7216. (Pubitemid 350276908)
53. Redon R, Ishikawa S, Fitch KR, et al. Global variation in copy number in the human genome. Nature 2006; 444: 444-454. (Pubitemid 44809057)
54. Guryev V, Saar K, Adamovic T, et al. Distribution and functional impact of DNA copy number variation in the rat. Nat Genet 2008; 40: 538-545. (Pubitemid 351601223)
55. Lee JA, Madrid RE, Sperle K, et al. Spastic paraplegia type 2 associated with axonal neuropathy and apparent PLP1 position effect. Ann Neurol 2006; 59: 398-403. (Pubitemid 43202498)
56. Montavon T, Le Garrec JF, Kerszberg M, et al. Modeling Hox gene regulation in digits: reverse collinearity and the molecular origin of thumbness. Genes Dev 2008; 22: 346-359. (Pubitemid 351214276)
57. Bruder CE, Piotrowski A, Gijsbers AA, et al. Phenotypically concordant and discordant monozygotic twins display different DNA copy-number-variation profiles. Am J Hum Genet 2008; 82: 763-771.
58. Piotrowski A, Bruder CE, Andersson R, et al. Somatic mosaicism for copy number variation in differentiated human tissues. Hum Mutat 2008; 29: 1118-1124.
59. Hastings PJ, Lupski JR, Rosenberg SM, et al. Mechanisms of change in gene copy number. Nat Rev Genet 2009; 10: 551-564.
60. Pacifici GM, Franchi M, Bencini C, et al. Tissue distribution of drug-metabolizing enzymes in humans. Xenobiotica 1988; 18: 849-856.
61. Hackett NR, Heguy A, Harvey BG, et al. Variability of antioxidant-related gene expression in the airway epithelium of cigarette smokers. Am J Respir Cell Mol Biol 2003; 29: 331-343.
62. Spira A, Beane J, Shah V, et al. Effects of cigarette smoke on the human airway epithelial cell transcriptome. Proc Natl Acad Sci USA 2004; 101: 10143-10148. (Pubitemid 38891209)
63. Adair-Kirk TL, Atkinson JJ, Griffin GL, et al. Distal airways in mice exposed to cigarette smoke: Nrf2-regulated genes are increased in Clara cells. Am J Respir Cell Mol Biol 2008; 39: 400-411.
64. Seidegard J, Pero RW, Stille B. Identification of the trans-stilbene oxide-active glutathione transferase in human mononuclear leukocytes and in liver as GST1. Biochem Genet 1989; 27: 253-261. (Pubitemid 19158519)
65. Comstock KE, Johnson KJ, Rifenbery D, et al. Isolation and analysis of the gene and cDNA for a human Mu class glutathione S-transferase, GSTM4. J Biol Chem 1993; 268: 16958-16965. (Pubitemid 23236919)
66. Soni M, Madurantakan M, Krishnaswamy K. Glutathione S-transferase Mu (GST Mu) deficiency and DNA adducts in lymphocytes of smokers. Toxicology 1998; 126: 155-162.
67. Kearns PR, Chrzanowska-Lightowlers ZM, Pieters R, et al. μ class glutathione S-transferase mRNA isoform expression in acute lymphoblastic leukaemia. Br J Haematol 2003; 120: 80-88. (Pubitemid 36056912)
68. Hofmann T, Kuhnert A, Schubert A, et al. Modulation of detoxification enzymes by watercress: in vitro and in vivo investigations in human peripheral blood cells. Eur J Nutr 2009; 48: 483-491.
69. Brockmoller J, Gross D, Kerb R, et al. Correlation between trans-stilbene oxide-glutathione conjugation activity and the deletion mutation in the glutathione S-transferase class μ gene detected by polymerase chain reaction. Biochem Pharmacol 1992; 43: 647-650.
70. Phillips DH. DNA adducts as markers of exposure and risk. Mutat Res 2005; 577: 284-292. (Pubitemid 41225507)
71. Seidegard J, Vorachek WR, Pero RW, et al. Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion. Proc Natl Acad Sci USA 1988; 85: 7293-7297.
72. Pemble S, Schroeder KR, Spencer SR, et al. Human glutathione S-transferase θ (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem J 1994; 300: 271-276.
73. Xu S, Wang Y, Roe B, et al. Characterization of the human class Mu glutathione S-transferase gene cluster and the GSTM1 deletion. J Biol Chem 1998; 273: 3517-3527. (Pubitemid 28109774)
74. Bolt HM, Thier R. Relevance of the deletion polymorphisms of the glutathione S-transferases GSTT1 and GSTM1 in pharmacology and toxicology. Curr Drug Metab 2006; 7: 613-628. (Pubitemid 44226589)
75. Sprenger R, Schlagenhaufer R, Kerb R, et al. Characterization of the glutathione S-transferase GSTT1 deletion: discrimination of all genotypes by polymerase chain reaction indicates a trimodular genotype-phenotype correlation. Pharmacogenetics 2000; 10: 557-565.
76. Rebbeck TR. Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol Biomarkers Prev 1997; 6: 733-743. (Pubitemid 27427630)
77. McLellan RA, Oscarson M, Alexandrie AK, et al. Characterization of a human glutathione S-transferase μ cluster containing a duplicated GSTM1 gene that causes ultrarapid enzyme activity. Mol Pharmacol 1997; 52: 958-965. (Pubitemid 28013713)
78. Liu G, Miller DP, Zhou W, et al. Differential association of the codon 72 p53 and GSTM1 polymorphisms on histological subtype of non-small cell lung carcinoma. Cancer Res 2001; 61: 8718-8722. (Pubitemid 34013882)
79. Miller DP, Liu G, de VI, et al. Combinations of the variant genotypes of GSTP1, GSTM1, and p53 are associated with an increased lung cancer risk. Cancer Res 2002; 62: 2819-2823.
80. Wang BG, Chen SD, Zhou WP, et al. [A case control study on the impact of CYP450 MSPI and GST-M1 polymorphisms on the risk of lung cancer]. Zhonghua Zhong Liu Za Zhi 2004; 26: 93-97.
81. Calikoglu M, Tamer L, Ates AN, et al. The association between polymorphic genotypes of glutathione S-transferases and COPD in the Turkish population. Biochem Genet 2006; 44: 307-319. (Pubitemid 46020298)